Clinical application prospects of Nectin-4 in pan-cancer: an analysis based on the Trialtrove database - PubMed
a day ago
- #Nectin-4
- #Pan-cancer
- #Antibody-drug conjugates
- Analysis of 136 interventional trials targeting Nectin-4 across various malignancies.
- Dominance of antibody-drug conjugates (ADCs) in clinical trials, especially for urothelial carcinoma.
- Significant exploration of combination regimens and diverse therapeutic modalities.
- Highlights the translational potential of Nectin-4 in cancer therapy.
- Key trends in clinical development of Nectin-4-targeted therapies identified.